Inventor
SRINIVASAN MOHAN
US78 patents
⚠️ This page may combine multiple inventors who share the name “SRINIVASAN MOHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
15 patentsUS9505839B2Nov 29, 2016
Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
BRISTOL MYERS SQUIBB CO123 citations99
US9228016B2Jan 5, 2016
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
BRISTOL MYERS SQUIBB CO85 citations98
US10377824B2Aug 13, 2019
Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
BRISTOL MYERS SQUIBB CO19 citations94
US10266591B2Apr 23, 2019
Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
BRISTOL MYERS SQUIBB CO20 citations94
US10189902B2Jan 29, 2019
Antibodies to TIGIT
BRISTOL MYERS SQUIBB CO27 citations93
US10100129B2Oct 16, 2018
Antibodies against CD73 and uses thereof
BRISTOL MYERS SQUIBB CO24 citations93
US9605080B2Mar 28, 2017
Antibodies against CD73
BRISTOL MYERS SQUIBB CO31 citations93
US10465010B2Nov 5, 2019
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
BRISTOL MYERS SQUIBB CO9 citations92
US9745379B2Aug 29, 2017
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
BRISTOL MYERS SQUIBB CO11 citations92
US8945553B2Feb 3, 2015
Bispecific antibodies to IL-23 and IL-17A/F
BRISTOL MYERS SQUIBB CO16 citations91
US11345752B2May 31, 2022
Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
BRISTOL MYERS SQUIBB CO4 citations84
US11084881B2Aug 10, 2021
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
BRISTOL MYERS SQUIBB CO3 citations84
US10501550B2Dec 10, 2019
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
BRISTOL MYERS SQUIBB CO9 citations84
US10653791B2May 19, 2020
Antibodies comprising modified heavy constant regions
BRISTOL MYERS SQUIBB CO10 citations83
US9644032B2May 9, 2017
Antibodies against OX40 and uses thereof
BRISTOL MYERS SQUIBB CO12 citations81
SQUIBB & SONS LLC
10 patentsUS9580507B2Feb 28, 2017
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
SQUIBB & SONS LLC129 citations99
US9492539B2Nov 15, 2016
Monoclonal antibodies to Programmed Death 1 (PD-1)
SQUIBB & SONS LLC119 citations99
US9492540B2Nov 15, 2016
Methods for treating cancer using anti-PD-1 antibodies
SQUIBB & SONS LLC139 citations99
US9387247B2Jul 12, 2016
Monoclonal antibodies to programmed death 1 (PD-1)
SQUIBB & SONS LLC124 citations99
US9358289B2Jun 7, 2016
Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodies
SQUIBB & SONS LLC137 citations99
US9273135B2Mar 1, 2016
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
SQUIBB & SONS LLC109 citations99
US9580505B2Feb 28, 2017
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
SQUIBB & SONS LLC37 citations98
US10441655B2Oct 15, 2019
Monoclonal antibodies to programmed death 1 (PD-1)
SQUIBB & SONS LLC25 citations94
US11072664B2Jul 27, 2021
Interferon receptor 1 antibodies and their uses
SQUIBB & SONS LLC3 citations73
US10385133B2Aug 20, 2019
Interferon receptor 1 antibodies and their uses
SQUIBB & SONS LLC2 citations73
NETWORK APPLIANCE INC
7 patentsUS7107385B2Sep 12, 2006
Storage virtualization by layering virtual disk objects on a file system
NETWORK APPLIANCE INC279 citations98
US7260737B1Aug 21, 2007
System and method for transport-level failover of FCP devices in a cluster
NETWORK APPLIANCE INC86 citations96
US7330862B1Feb 12, 2008
Zero copy write datapath
NETWORK APPLIANCE INC27 citations92
US7293152B1Nov 6, 2007
Consistent logical naming of initiator groups
NETWORK APPLIANCE INC25 citations92
US7181439B1Feb 20, 2007
System and method for transparently accessing a virtual disk using a file-based protocol
NETWORK APPLIANCE INC32 citations92
US7523201B2Apr 21, 2009
System and method for optimized lun masking
NETWORK APPLIANCE INC13 citations84
US7512832B1Mar 31, 2009
System and method for transport-level failover of FCP devices in a cluster
NETWORK APPLIANCE INC13 citations84
MEDAREX INC
6 patentsUS9102725B2Aug 11, 2015
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
MEDAREX INC120 citations99
US8383796B2Feb 26, 2013
Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)
MEDAREX INC355 citations99
US8008449B2Aug 30, 2011
Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
MEDAREX INC2,199 citations99
US7943743B2May 17, 2011
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
MEDAREX INC1,485 citations99
US7662381B2Feb 16, 2010
Interferon alpha receptor 1 antibodies and their uses
MEDAREX INC47 citations98
US7456264B2Nov 25, 2008
Human monoclonal antibodies against Bacillus anthracis protective antigen
MEDAREX INC88 citations96
NETAPP INC
4 patentsUS7873700B2Jan 18, 2011
Multi-protocol storage appliance that provides integrated support for file and block access protocols
NETAPP INC106 citations97
US7917539B1Mar 29, 2011
Zero copy write datapath
NETAPP INC16 citations92
US7904482B2Mar 8, 2011
System and method for transparently accessing a virtual disk using a file-based protocol
NETAPP INC30 citations92
US7739543B1Jun 15, 2010
System and method for transport-level failover for loosely coupled iSCSI target devices
NETAPP INC23 citations92
KORMAN ALAN
2 patentsMEDAREX LLC
1 patentKORMAN ALAN J
1 patentSCHERING CORP
1 patentCARDARELLI JOSEPHINE M
1 patentDESHPANDE SHRIKANT
1 patentPOGUE SARAH L
1 patentShowing the top 50 of 78 patents by PatentIndex Score.